PRJNA639892 - KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [2] - OmicsDI

Genomics

Dataset Information

KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [2]

ABSTRACT: KDM5 inhibition is a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas [2]

PROVIDER: PRJNA639892 | ENA |

REPOSITORIES: ENA